OptimizeRx Corporation reports results for the quarter ended June 30 - Earnings Summary

OptimizeRx

12/08/2026 22:01

OptimizeRx Corporation OPRX.OQ reported quarterly adjusted earnings of 16 cents​​ per share for the quarter ended June 30, lower than the same quarter last year, when the company reported EPS of 24 cents.  The mean expectation of six analysts for the quarter was for earnings of 12 cents per share. Wall Street expected results to range from 8 cents to 15 cents per share.
Revenue fell 29.8% to $20.50 million from a year ago; analysts expected $20.20 million. 
OptimizeRx Corporation's reported EPS for the quarter was a loss of 4 cents​.
The company reported a quarterly loss of $703 thousand.
OptimizeRx Corporation shares had risen by 21.0% this quarter and lost 43.6% so far this year.
FORECAST CHANGES
The mean earnings estimate of analysts had fallen by about 14.9% in the last three months.​ 
In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.
RECOMMENDATIONS
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 6 "strong buy" or "buy," no "hold" and no "sell" or "strong sell." The average consensus recommendation for the online services peer group is also "buy" 
Wall Street's median 12-month price target for OptimizeRx Corporation is $11.00, about 37.1% above its last closing price of $6.92
This summary was machine generated from LSEG data August 12 at 09:01 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING
ESTIMATE 
ACTUAL
BEAT, MET, MISSED
Jun. 30 2026 
0.12
0.16
Beat
Mar. 31 2026 
0.00
0.14
Beat
Dec. 31 2025 
0.23
0.51
Beat
Sep. 30 2025 
0.04
0.20
Beat